Northern Trust’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-140,542
Closed -$21.4K 4593
2023
Q2
$21.4K Hold
140,542
﹤0.01% 4398
2023
Q1
$20.2K Buy
140,542
+57,003
+68% +$9.12K ﹤0.01% 4447
2022
Q4
$10K Hold
83,539
﹤0.01% 4573
2022
Q3
$15K Sell
83,539
-195
-0.2% -$105 ﹤0.01% 4597
2022
Q2
$148K Sell
83,734
-360,510
-81% -$809K ﹤0.01% 4036
2022
Q1
$1.34M Sell
444,244
-13,349
-3% -$35.7K ﹤0.01% 3288
2021
Q4
$1.7M Buy
457,593
+19,677
+4% +$115K ﹤0.01% 3305
2021
Q3
$2.6M Buy
437,916
+261,999
+149% +$3.68M ﹤0.01% 3138
2021
Q2
$3.06M Buy
175,917
+97,841
+125% +$1.78M ﹤0.01% 3141
2021
Q1
$1.49M Buy
78,076
+4,060
+5% +$74.1K ﹤0.01% 3404
2020
Q4
$1.29M Buy
+74,016
New +$886K ﹤0.01% 3404

Other funds holding HGEN

Northern Trust's HGEN Position: Q3 2023 in Review

Northern Trust sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 140,542 shares — an estimated $21.4K sold.

Northern Trust first reported a position in HGEN in Q4 2020 and held it in 11 quarters. The position peaked at $3.06M in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

  • Northern Trust reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
  • Northern Trust sold 140,542 HUMANIGEN, INC. shares in Q3 2023, an estimated $21.4K.
  • Northern Trust first reported a position in HUMANIGEN, INC. in Q4 2020 and held it in 11 quarters.
  • Northern Trust's HUMANIGEN, INC. position peaked at $3.06M in Q2 2021.
  • 3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Northern Trust's 13F filing for Q3 2023, filed 13 Nov 2023.